YC W21
Entelexo Biotherapeutics
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
About
Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.
Founders
- MILAD RIAZIFAR
- Todd Schurr
- Cameron Taylor
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Entelexo Biotherapeutics.
See family office activityIndustry & Focus
HealthcareTherapeuticsBiotech